Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Chinese tech giant Baidu launched its new flagship AI model, ERNIE 5.0, in Beijing on Thursday. The company unveiled the system at its Baidu World 2025 event. It is built to handle text, images, audio ...

The trend of AI researchers developing new, small open source generative models that outperform far larger, proprietary peers continued this week with yet another staggering advancement. The goal is ...

A week ago, Google disabled the ability to see 100 results per page by using a URL parameter in the Google Search URL bar. Since that change, rank-checking tools have become an absolute mess, and even ...

18 popular NPM packages with over 2 billion weekly downloads were compromised through a phishing attack targeting developer “Qix” The malware functioned as a “crypto-clipper,” silently replacing ...

Hello, and welcome, everybody, to Recursion's Q2 2025 Earnings Call. My name is Chris Gibson, and I'm the Co-Founder and CEO of Recursion. And I'm excited to share with you today some of the latest ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Tuesday reported a loss of $171.9 million in its second quarter. On a per-share basis, the Salt Lake City-based ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks to buy according to hedge funds. Earlier on June 6, a significant advancement in drug discovery was announced with the ...